A feverish Q1 2016
- During Q1 2016, SIPHAT recorded a 7% decline in sales, from TND10.2m in Q1 2015 to TND9.5m. This decline is mainly due to a significant decrease by 85% in Export revenues, as well as a 20% drop in tablet products revenues dedicated to the hospital sector on the back of the repair works in the tablet products laboratory.- Production has witnessed a decline of 17.53% to TND7.93m (down from TND9.61m in Q1 2015) due to a decrease of: -15% and -20% in the hospital model production and pharmaceutical model production, respectively.
AlphaMena is the MENA stocks leader in independent equity research, covering 142. MENA securities spanning across 19 sectors and 8 countries relaying on a team of 11 analysts. The breadth of coverage allows AlphaMena to formulate a coherent view on markets, sectors and to highlight the best investments in Mena zone using a robust homogeneous and transparent methodology, enabling pure and pertinent comparisons based on financial and extra-financial criteria.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.